MXPA06000660A - Uso de una composicion cosmetica o farmaceutica que comprende un extracto rico en lupeol, como un ingrediente activo para estimular la sintesis de proteinas de choque termico. - Google Patents

Uso de una composicion cosmetica o farmaceutica que comprende un extracto rico en lupeol, como un ingrediente activo para estimular la sintesis de proteinas de choque termico.

Info

Publication number
MXPA06000660A
MXPA06000660A MXPA06000660A MXPA06000660A MXPA06000660A MX PA06000660 A MXPA06000660 A MX PA06000660A MX PA06000660 A MXPA06000660 A MX PA06000660A MX PA06000660 A MXPA06000660 A MX PA06000660A MX PA06000660 A MXPA06000660 A MX PA06000660A
Authority
MX
Mexico
Prior art keywords
lupeol
pharmaceutical composition
cosmetic
rich extract
stimulating
Prior art date
Application number
MXPA06000660A
Other languages
English (en)
Inventor
Nathalie Piccardi
Original Assignee
Expanscience Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expanscience Lab filed Critical Expanscience Lab
Publication of MXPA06000660A publication Critical patent/MXPA06000660A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere al uso de un extracto rico en lupeol, en la produccion de una composicion cosmetica o farmaceutica para tratar y/o prevenir una degeneracion de tejido conectivo; dicha invencion se refiere tambien al uso de un extracto rico en lupeol, en la produccion de una composicion farmaceutica para prevenir y/o tratar patologias articulares no inflamatorias, enfermedades periodontales y marcas de esfuerzo; la invencion se refiere tambien al uso de un extracto rico en lupeol, en la produccion de una composicion cosmetica como un agente cicatrizante, un agente reestructurante y un agente anti-flacidez para la piel y/o mucosas.
MXPA06000660A 2003-07-18 2004-07-19 Uso de una composicion cosmetica o farmaceutica que comprende un extracto rico en lupeol, como un ingrediente activo para estimular la sintesis de proteinas de choque termico. MXPA06000660A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0308796A FR2857596B1 (fr) 2003-07-18 2003-07-18 Utilisation d'une composition cosmetique ou pharmaceutique comprenant un extrait riche en lupeol, a titre de principe actif, pour stimuler la synthese des proteines de stress
PCT/FR2004/001907 WO2005009331A2 (fr) 2003-07-18 2004-07-19 Utilisation d’une composition cosmetique ou pharmaceutique comprenant un extrait riche en lupeol a titre de principe actif pour stimuler la synthese des proteines de stress

Publications (1)

Publication Number Publication Date
MXPA06000660A true MXPA06000660A (es) 2006-03-30

Family

ID=33548249

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000660A MXPA06000660A (es) 2003-07-18 2004-07-19 Uso de una composicion cosmetica o farmaceutica que comprende un extracto rico en lupeol, como un ingrediente activo para estimular la sintesis de proteinas de choque termico.

Country Status (8)

Country Link
US (1) US8747815B2 (es)
EP (1) EP1648482B9 (es)
CN (1) CN100453092C (es)
ES (1) ES2406729T3 (es)
FR (1) FR2857596B1 (es)
HK (1) HK1089701A1 (es)
MX (1) MXPA06000660A (es)
WO (1) WO2005009331A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9089576B2 (en) 2004-04-30 2015-07-28 Laboratoires Expanscience Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin
FR2895677B1 (fr) * 2006-01-05 2012-05-25 Fabre Pierre Dermo Cosmetique Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillissement cutane.
FR2918068B1 (fr) * 2007-06-26 2011-05-13 Agence Internationale De L Embellissement Des Milieux Aquatiques A I E M A Procede et composition pour colorer les eaux de bassins de bains et/ou de baignades.
MX2010005213A (es) * 2007-11-28 2010-05-21 Colgate Palmolive Co Aductos de aceite de alfa o beta hidroxi acido.
RU2454993C2 (ru) * 2007-11-28 2012-07-10 Колгейт-Палмолив Компани Этоксилированный и/или гидрированный масляный аддукт
FR2948565B1 (fr) 2009-07-30 2011-10-28 Expanscience Lab Composition cosmetique pour le traitement de l'acne comprenant un extrait petidique de schizandra
FR2948566B1 (fr) 2009-07-30 2012-08-10 Expanscience Lab Extrait du fruit de schizandra sphenanthera et compositions cosmetiques, dermatologiques et nutraceutiques le comprenant
FR2953135B1 (fr) 2009-11-30 2012-05-11 Expanscience Lab Extrait de graines d'acacia macrostachya et compositions cosmetiques, pharmaceutiques, dermatologiques, nutraceutiques ou alimentaires le comprenant
FR2953136B1 (fr) 2009-11-30 2012-05-11 Expanscience Lab Extrait de graines de vigna unguiculata et compositions cosmetiques, pharmaceutiques, dermatologiques, nutraceutiques ou alimentaires le comprenant
FR2953722B1 (fr) 2009-12-16 2012-03-09 Expanscience Lab Composition comprenant au moins un sucre en c7 pour le traitement de l'alopecie, pour le traitement cosmetique des phaneres, et pour le soin des cheveux, cils ou ongles
FR2969495B1 (fr) 2010-12-22 2013-10-11 Expanscience Lab Extrait de parties aeriennes de maca riche en polyphenols et composition le comprenant
FR2969496B1 (fr) 2010-12-22 2013-11-08 Expanscience Lab Extrait de pulpe et/ou de peau d'avocat riche en polyphenols et compositions cosmetiques, dermatologiques et nutraceutiques le comprenant
FR2975004B1 (fr) 2011-05-13 2013-06-28 Expanscience Lab Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
FR2977797B1 (fr) 2011-07-13 2014-01-17 Urgo Lab Utilisation cosmetique et/ou dermatologique de composes oligosaccharidiques pour la prevention et le traitement des vergetures
FR2999429B1 (fr) 2012-12-18 2015-01-02 Expanscience Lab Extrait de graines de passiflore et compositions cosmetiques, pharmaceutiques, dermatologiques ou nutraceutiques le comprenant
FR3001889B1 (fr) 2013-02-11 2021-02-12 Expanscience Lab Utilisation d'une composition comprenant un perseose d'avocat dans la protection des cellules souches epidermiques .
FR3011008B1 (fr) 2013-09-24 2017-12-29 Expanscience Lab Procedes d'evaluation des effets deleteres des uv sur la peau d'enfant
FR3010906B1 (fr) 2013-09-25 2016-12-23 Expanscience Lab Extrait lipidique de graines de passiflores
FR3016373B1 (fr) 2014-01-10 2018-01-19 Laboratoires Expanscience Modele de peau de mammelon reconstitue
FR3028764B1 (fr) 2014-11-26 2016-12-09 Expanscience Lab Extrait peptidique et osidique de fruit de schizandra et amelioration de la reponse du systeme neurosensoriel cutane
WO2018063010A1 (en) 2016-09-29 2018-04-05 Politechnika Krakowska im.Tadeusza Kościuszki Novel lupeol derivative and the method of obtaining the novel lupeol derivative
FR3098405B1 (fr) 2019-07-12 2021-06-25 Expanscience Lab Composition comprenant des polyphénols de graines de passiflore, des peptides d’avocat et un extrait d’hamamélis et utilisation pour traiter et/ou prévenir les vergetures
CN115227632B (zh) * 2022-08-03 2024-04-26 广东馨柯生命科学有限公司 一种富含牡丹提取物Essenpure PRE的消炎抗菌的温和洁面慕斯及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190979A (en) * 1988-06-24 1993-03-02 Stephen Herman Ozonides of terpenes and their medical uses
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
FR2762512B1 (fr) * 1997-04-24 2000-10-13 Pharmascience Lab Compositions a base d'huile de lupin, notamment a base d'huile de lupin et d'huile de germe de ble et leur utilisation en cosmetologie, en pharmacie et en tant que complement alimentaire
FR2778565B1 (fr) * 1998-05-14 2000-07-28 Silab Sa Procede d'extraction de principes actifs vegetaux a partir de graines de lupin blanc doux, extrait obtenu et composition utilisant au moins une fraction de cet extrait
FR2822821B1 (fr) * 2001-04-03 2004-05-07 Pharmascience Lab Extrait de coques de graines de lupin contenant du lupeol, en particulier extrait riche en lupeol et son procede de preparation

Also Published As

Publication number Publication date
EP1648482A2 (fr) 2006-04-26
US20060216249A1 (en) 2006-09-28
EP1648482B9 (fr) 2013-07-10
HK1089701A1 (en) 2006-12-08
WO2005009331A3 (fr) 2005-03-24
FR2857596A1 (fr) 2005-01-21
ES2406729T3 (es) 2013-06-07
CN100453092C (zh) 2009-01-21
US8747815B2 (en) 2014-06-10
WO2005009331A2 (fr) 2005-02-03
EP1648482B1 (fr) 2013-03-20
FR2857596B1 (fr) 2006-02-03
CN1826127A (zh) 2006-08-30

Similar Documents

Publication Publication Date Title
MXPA06000660A (es) Uso de una composicion cosmetica o farmaceutica que comprende un extracto rico en lupeol, como un ingrediente activo para estimular la sintesis de proteinas de choque termico.
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
BRPI0416801A (pt) derivados de 1h-imidazoquinolina como inibidores de proteìna sinase
HK1057752A1 (en) N-phenyl-2-pyrimidine-amine derivatives
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
ATE381535T1 (de) Phenethanolaminderivate
WO2007046097A3 (en) Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
BR0312549A (pt) Derivados de indolin-fenilsulfonamida
ES2187300A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
MXPA05004247A (es) Cromonas y derivados de cromona y usos de los mismos.
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
BRPI0411503A (pt) composto, composição farmacêutica, uso de um composto, método de tratar um ser humano que sofre de uma doença hiperproliferativa tal como cáncer, e, processo para a preparação de um composto
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
PT1893237E (pt) Composição farmacêutica compreendendo um elastómero organopolissiloxano e um princípio activo solubilizado
TW200501963A (en) Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
WO2004087700A8 (fr) Derives du benzenesulfonamide, leur procede de preparation et leur utilisation de la douleur
MXPA05014184A (es) Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral.
PL346143A1 (en) Tan-1057 derivatives
WO2007044574A3 (en) Pharmaceutical compositions, methods of preparation thereof, and methods of treatment
WO2003024996A3 (de) Antibakterielle makrozyklen
HUP0204258A3 (en) Use of vitamin d-derivatives for preparation of pharmaceutical compositions useful in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives

Legal Events

Date Code Title Description
FG Grant or registration